Serological survey of immunity to tetanus in adult population of Northern Halkidiki, Greece

European Journal of Epidemiology

Volumn 18, Issue 12, 2003, Pages 1147-1152

  Symeonidis, Nikolaos ^a   Symeonidis, Chrysanthos ^a   Souliou, Efimia ^a   Houiazi, Eudoxia ^a   Diza, Efterpi ^a   Symeonidis, Athanassios ^a   Antoniadis, Antonios ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Immunity; Tetanus; Tetanus antitoxin; Vaccination

Indexed keywords

TETANUS ANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLOSTRIDIUM TETANI; ENZYME LINKED IMMUNOSORBENT ASSAY; EVALUATION; FEMALE; GEOGRAPHIC DISTRIBUTION; GEOMETRY; GREECE; HUMAN; HUMAN EXPERIMENT; IMMUNITY; LABORATORY TEST; MALE; NORMAL HUMAN; POPULATION RISK; RURAL POPULATION; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; TETANUS;

ADULT; AGED; AGED, 80 AND OVER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GREECE; HUMANS; MALE; MIDDLE AGED; TETANUS; TETANUS ANTITOXIN;

EID: 0346458883     PISSN: 03932990     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:EJEP.0000006629.35774.31     Document Type: Article

References (45)

1. Bleck TP, Brauner JS. Tetanus. In: Scheld WM, Whitley RJ, Durack DT (eds), Infections of the Central Nervous System, 2nd ed. Philadelphia: Lippincott-Raven, 1997: 629-653.
2. Centers for Disease Control. Progress towards the global elimination of neonatal tetanus, 1988-1993. MMWR 1994; 43: 885-894.
3. Centers for Disease Control. Tetanus surveillance-United States, 1995-1997. MMWR 1998; 47: 1-13.
4. Steger MM, Maczek C, Berger P, et al. Vaccination against tetanus in elderly: Do recommended strategies give sufficient protection? Lancet 1996; 348: 762.
5. Karalliedde L, Cumberland N, Alexander C. Unfinished business: Adult immunization against tetanus. World Health Forum 1995; 16: 374-376.
6. Center for Disease Control and Prevention. Summary of notifiable diseases, United States 1994. MMWR Morbid Mortal Wkly Rep 1994; 43: 1.
7. Gergen PJ, McQuillan GM, Kiely M, Ezzati-Rice TM, Sutter RW, Virella G. A population based serologic survey of immunity to tetanus in the United States. N Eng J Med 1995; 332(12): 761-766.
8. Faust RA, Vickers OR, Cohn I Jr. Tetanus: 2449 cases in 68 years at Charity Hospital. J Trauma 1976; 16: 704-712.
9. Center for Disease Control and Prevention. Tetanus surveillance - United States, 1991-1994. MMWR CDC Surveill Summ 1997; 46(SS-2): 15.
10. Middlebrook JL, Brown JE. Immunodiagnosis and immunotherapy of tetanus and botulinum neurotoxins. Curr Top Microbiol Immunol 1995; 195: 89-122.
11. Alagappan K, Rennie W, Kwiatkowski T, et al. Sero-prevalence of tetanus antibodies among adults older than 65 years. Ann Emerg Med 1996; 28(1): 18-21.
12. Hsu SS, Groleau G. Tetanus in the emergency department: A current review. J Emerg Med 2001; 20(4): 357-365.
13. MMWR. Neonatal tetanus - Montana, 1998. Morb Mortal Wkly Rep 1998; 47(43): 928-930.
14. Fair E, Murphy TV, Golaz A, Wharton M. Philosophic objection to vaccination as a risk for tetanus among children younger than 15 years. Pediatrics 2002; 109(1): E2.
15. Prospero E, Appignanesi R, D'Errico MM, Carle F. Epidemiology of tetanus in the Marches Region of Italy, 1992-1995. Bull World Health Organ 1998; 76(1): 47-54.
16. Valentino M, Rapisarda V. Tetanus in a central Italian region: Scope for more effective prevention among unvaccinated agricultural workers. Occup Med (Lond) 2001; 51(2): 114-117.
17. Peetermans WE, Schepens D. Tetanus - still a topic of present interest: A report of 27 cases from a Belgian referral hospital. J Intern Med 1996; 239(3): 249-252.
18. Yildirim RC, Yilmaz N, Yildirim U, Aksakal FN. Tetanus IgG antibody levels in children aged 12 to 47 months in Turkey. Am J Infect Control 2001; 29(2): 120-123.
19. Tomaszunas-Blaszczyk J. Tetanus in 1997. Przegl Epidemiol 1999; 53(1-2): 129-135.
20. Zielinski A. Tetanus in 1998. Przegl Epidemiol 2000; 54(1-2): 151-156.
21. Zielinski A. Tetanus in 1999. Przegl Epidemiol 2001; 55(1-2): 137-140.
22. Patel JC, Mehta BC. Tetanus: Study of 8697 cases. Indian J Med Sci 1999; 53(9): 393-401.
23. Lee HC, Ko WC, Chuang YC. Tetanus of the elderly. J Microbiol Immunol Infect 2000; 33(3): 191-196.
24. Lau LG, Kong KO, Chew PH. A ten-year retrospective study of tetanus at a general hospital in Malaysia. Singapore Med J 2001; 42(8): 346-350.
25. Social Welfare and health statistics. Hellenic Republic National Statistical Service of Greece, Athens, 1970-1997.
26. Schröder JP, et al. Vermeidung Hyperegischer Reaktionen bei Tetanus - Impfungen durch Einsatz eines wissenbasierten Systems bei Fragen der Impfunotwendigkeit. Klin Lab 1992; 38: 229-233.
27. Wenner GT, et al. Tetanus immunität im Alter. Zeitschrift für Gerontologie 1983; 16: 130-133.
28. Müller HE, et al. Tetanus - Schutzimpfung - Indikation und Kontraindikation. Dtsch Med Wsch 1988; 113: 1326-1328.
29. Souliou-Simeonidou E, Diza-Mataftsi E, Kyriazopoulou-Dalaina B, Frantzidou-Adamopoulou F, Papapanagiotou I. Evaluation of the immunity status of the population against Clostridium tetani. Acta Microbiol Hellenica 1985; 30: 184-198.
30. de Melker HE, van de Hof S, Berbers GA, Nagelkerke NJ, Rumke HC, Conyn-van Spaendonck MA. A population-based study on tetanus antitoxin levels in The Netherlands. Vaccine 1999; 18(1-2): 100-108.
31. Reid PM, Brown D, Coni N, Sama A, Waters M. Tetanus immunization in the elderly population. J Accid Emerg Med 1996; 13(3): 184-185.
32. Maple PA, Jones CS, Wall EC, et al. Immunity to diphtheria and tetanus in England and Wales. Vaccine 2000; 19(2-3): 167-173.
33. Heath TC, Smith W, Capon AG, Hanlon M, Mitchell P. Tetanus immunity in an older Australian population. Med J Aust 1996; 164(10): 593-596.
34. Cilla G, Saenz-Dominguez JR, Montes M, Part C, Perez-Trallero E. Immunity against tetanus in adults over the age of 49 years. Med Clin (Barc) 1994; 130(15): 571-573.
35. Stark K, Schonfeld C, Barg J, Molz B, Vornwald A, Bienzle U. Seroprevalence and determinants of diphtheria, tetanus and poliomyelitis antibodies among adults in Berlin, Germany. Vaccine 1999; 17(7-8): 844-850.
36. Yuan L, Lau W, Thipphawong J, Kasenda M, Xie F, Bevilacqua J. Diphtheria and tetanus immunity among blood donors in Toronto. CMAJ 1997; 156(7): 985-990.
37. Brabek E, Kranke B, Stunzner D, Aberer W. Epidemiologic data for tetanus prophylaxis. Assessment of the need for vaccination. Wien Klin Wochenschr 1999; 111(20): 851-854.
38. Ergonul O, Sozen T, Tekeli E. Immunity to tetanus among adults in Turkey. Scand J Infect Dis 2001; 33(10): 728-730.
39. Klouche M, Gorg S, Wilhelm D, Kirchner H. Sex and age-dependent gaps in tetanus immunization. Dtsch Med Wochenschr 1994; 119(23): 827-832.
40. Ortega P, Gil A, Astasio P, et al. Prevalence of antibodies against tetanus, diphtheria and Bordetella pertussis in health care professionals. Enferm Infecc Microbiol Clin 1999; 17(3): 135-137.
41. e Session des Journées Médical Balkaniques. 30 Août-4 Septembre 1983. Thessaloniki-Grèce.
42. Durbaca S. Antidiphtheria and antitetanus immunity of recruits in Romania. Roum Arch Microbiol Immunol 1996; 55(4): 295-303.
43. Alagappan K, Rennie W, Lin D, Auerbach C. Immunologic response to tetanus toxoid in the elderly: One-year follow up. Ann Emerg Med 1998; 32(2): 155-160.
44. Palomo Cobos L. Effectiveness of tetanus vaccination in an adult population 10 years after the last dose. Aten Primaria 1994; 14(4): 707-710.
45. CDC: Tetanus Surveillance - United States, 1989 and 1990. MMWR 1992; 41(SS-8): 1.